Factor VII 抗体 (C-Term, Phe7)
Our Local Distributor
北京 101111
Quick Overview for Factor VII 抗体 (C-Term, Phe7) (ABIN2235832)
抗原
See all Factor VII (F7) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- C-Term, Phe7
-
交叉反应
- 人
-
交叉反应 (详细)
- Calculated cross reactivity: Hu
-
产品特性
- Coagulation factor VII (F7) (SPCA, eptacog alfa, factor VII, FVII coagulation protein, Proconvertin, Serum prothrombin conversion accelerator, , INN)
-
纯化方法
- Purified by immunoaffinity chromatography.
-
免疫原
- A synthetic peptide corresponding to a sequence at the C-terminal of human F7.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working conditions should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
缓冲液
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
储存液
- Sodium azide, Thimerosal (Merthiolate)
-
注意事项
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 4°C/-20°C
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
别名
- Coagulation Factor VII
-
UniProt
- P08709
-
途径
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
抗原
-